Association of c-myc Overexpression and Hyperproliferation with Arsenite-Induced Malignant Transformation
- 15 September 2001
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 175 (3), 260-268
- https://doi.org/10.1006/taap.2001.9253
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technologyMolecular Carcinogenesis, 2001
- Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperatureOncogene, 1999
- Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastasesCancer, 1999
- Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth FactorsThe American Journal of Pathology, 1998
- Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factorsMutation Research - Reviews in Mutation Research, 1997
- ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITYAnnual Review of Pharmacology and Toxicology, 1997
- Arsenic induces overexpression of growth factors in human keratinocytesToxicology and Applied Pharmacology, 1996
- Beating a path to MycNature, 1995
- Alterations in DNA methylation may play a variety of roles in carcinogenesisCell, 1995
- Toxicological and Pathological Applications of Proliferating Cell Nuclear Antigen (PCNA), A Novel Endogenous Marker for Cell ProliferationCritical Reviews in Toxicology, 1993